From the Institute of Gene Biology,
34/5 Vavilova St., Moscow 117334, Russia and the
Danish Cancer
Society, Strandboulevarden 49, 7.1, DK-2100 Copenhagen, Denmark
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cloning of the mouse tag7 gene
encoding a novel cytokine is described. The Tag7 protein consists of
182 amino acids. Genomic organization of the tag7 gene and
its promoter region remind those of the genes of the tumor necrosis
factor locus, although the tag7 gene is not linked to this
locus. The gene is located on chromosome 7 at the area that corresponds
to band 7A3, which has genetic linkage with lupus-like disease in mouse
models. tag7 transcription is essential for lymphoid
organs. It is also detected in certain areas of lungs, brain, and
intestine and in some tumors. Tag7 protein is detectable in both
cell-associated and soluble forms. The soluble form of Tag7 triggers
apoptosis in mouse L929 cells in vitro and does not involve
NF-B activation. The relationship between Tag7 and tumor necrosis
factor family of ligands is discussed.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The term "cytokine" has come to be used for a diverse group of growth factors, inflammatory mediators, and hematopoietic regulators that are distinct from more classical hormones secreted by the glands of the endocrine system. Cytokines are proteins that act as a soluble cell to cell messengers, distinguished by their high interactivity, and can act in both autocrine and paracrine manners.
Neoplastic cells themselves characteristically produce cytokines
spontaneously, and even in the same lineage, they can have distinct
cytokine expression and/or secretion profiles (1-4). Cytokines
secreted by tumors could be used either as autocrine factors, to
recruit and suppress reactive leukocytes, or to modulate the activity
of endothelial and stromal cells. The ability to release cytokine in an
autocrine manner could be a key factor in the promotion of neoplastic
transformation and in permitting tumor growth in vivo (5).
In their turn, cytokines produced by the host in response to a tumor
modify the scenario created by tumor growth (6). The analysis of
expression of cytokine genes by tumors indicated that cells
constitutively produced both autostimulatory and inhibitory cytokines.
Expression of several cytokines, including interleukin-1
(IL-1
),1 IL-6, IL-8,
IL-10, tumor necrosis factor-
, lymphotoxin-
, and granulocyte-macrophage colony-stimulating factor by some tumors has
been described. Tumor necrosis factor (TNF) and lymphotoxin-
(LT-
, also known as TNF-
) are related cytokines involved in many
regulatory activities (7, 8), but their roles in the immune system
although suggesting very critical functions (9) are still enigmas. TNF
and LT-
are released by a number of tumor cells originating in mouse
fibrosarcoma, epithelial human cell lines, and T-cell leukemia
(10-12).
In this study, we used a pair of related mouse transplanted tumors with the opposite metastatic properties to identify genes overexpressed in one of them. As a result, the tag7 gene was cloned. It was expressed in tumor with high metastatic potential, although no correlation with metastatic potential was detected after study of many different tumors. The tag7 gene is preferentially transcribed in normal lymphoid and hematopoietic cells. Tag7 is a secreted protein possessing a significant cytotoxicity realized through apoptosis.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cells and Cell Cultures-- VMR-0, VMR-L, CSML-0, and CSML-100 cell lines were established from their respective mammary adenocarcinoma transplanted tumors described in Ref. 13. Cell lines saved their ability to produce tumors in syngenetic mice with low (VMR-0 and CSML-0) and high (VMR-L and CSML-100) metastatic potential when injected subcutaneously. Mouse splenocytes, thymocytes, monocytes, and peritoneal macrophages were isolated as described previously (14). Cells were cultured in RPMI 1640 medium containing 5% FBS 100 units/ml penicillin, 100 units/ml streptomycin, 10 mM HEPES. Cells were activated with LPS (5 µg/ml) in serum-free medium for different time. VMR-0 cells were transfected with the pM5Gneo tag7 construct or mock-transfected using Lipofectin reagent (Life Technologies, Inc.) according to the manufacturer's recommendations, and clones were selected on G418 resistance and maintained.
Cloning of the tag7 Gene--
A fragment of the tag7
cDNA was isolated by differential display technique essentially as
described by Liang and Pardee (15). T12AC oligonucleotide
was used as the anchoring primer, and AATCGGGCTG was used as the
arbitrary primer. A fragment of 390 bp was used as a probe for Northern
blot hybridization and cDNA library screening (16). cDNA
library was prepared on poly(A)+ RNA isolated from VMR-L
tumors using ZAP-cDNA Gigapack Cloning kit (Stratagene) according
to the manufacturer's recommendation. Positive clones were purified,
and the inserts were excised as pBluescript clones using helper phage
as described by the manufacturer. Few clones were sequenced using
Sequenase Version 2.0 sequencing kit (Amersham Pharmacia Biotech) and
synthetic oligonucleotide primers (Applied Biosystems 391 DNA
synthesizer). Genomic library was constructed in the FIX II vector
(Stratagene) and screened according to a standard procedure (16). The
inserts were subcloned in pGEM7Z vector and partially sequenced as
described above.
RNA Hybridization-- Total RNA from tumors and cell lines was isolated by guanidine thiocyanate procedure, resolved on a 1.2% agarose-formaldehyde gel, and blotted onto Hybond-N as recommended by the manufacturer (Amersham Pharmacia Biotech). The EcoRI/XhoI fragment from the longest cDNA clone was labeled by random priming and used as a probe. To equalize an amount of RNA loaded on each lane, hybridization with glyceraldehyde-3-phosphate dehydrogenase DNA probe was performed. In situ hybridization was performed as described previously (17).
DNAs-- Oligonucleotides were synthesized corresponding to the 5' and 3' ends of the coding regions of the mouse tag7 gene, with BamHI and HindIII restriction sites appended to the ends of oligonucleotides. The coding region of the gene was amplified by standard polymerase chain reaction techniques, cut with BamHI and HindIII, and inserted in frame in the BamHI and HindIII sites of the pQE30 expression vector (Qiagen). For eucaryotic expression, full-sized tag7 cDNA was subcloned in NheI-XhoI sites of pBK-CMV (Stratagene) and EcoRI-BamHI sites of pM5Gneo vectors.
Chromosomal Mapping of the tag7 Gene-- Fluorescence in situ hybridization on metaphase mouse chromosomes was performed by Genome Systems, Inc.
Immunological Methods-- Escherichia coli recombinant Tag7 protein was expressed in M15[pREP4] (Qiagen) and purified on Ni-NTA agarose (Qiagen) as recommended by the manufacturer. Rabbit antibodies raised against recombinant Tag7 were affinity-purified on a Sepharose (Amersham Pharmacia Biotech) column with the immobilized recombinant Tag7, as recommended by the manufacturer. SDS-polyacrylamide gel electrophoresis, immunoprecipitation, and immunoblotting were performed according to standard procedures (16). The approximate amount of secreted Tag7 by VMRSX8 clone was determined by immunoblotting.
Analysis of Tag7 Multimeric Structure--
Mouse splenocytes
(1.5 × 108 cells) were treated with LPS for 18 h
on two 100-mm dishes as described above. After that, Complete Mini
EDTA-free protease inhibitor mix (Boehringer Mannheim) and EDTA to
final concentration 1 mM were added to conditioned medium. Conditioned medium was concentrated and fractionated on Superdex 75 HR10/30 column (Amersham Pharmacia Biotech) in 20 mM
Tris-HCl, pH 7.5, 100 mM NaCl according to the
manufacturer's recommendation. For column calibration, bovine milk
-lactalbumin (14.2 kDa), bovine erythrocyte carbonic anhydrase (29 kDa), and chicken egg ovalbumin (45 kDa) (Sigma) were used. Proteins
from collected fractions were precipitated with trichloroacetic acid,
resolved by 15% SDS-polyacrylamide gel electrophoresis, and
transferred to membrane. The membrane was then probed with anti-Tag7
polyclonal antiserum.
Tag7 Cytotoxicity Assay and Neutralization of Cytotoxic Activity-- As a source of the native form of the Tag7 protein, the medium conditioned by the VMR-0 pM5Gneo tag7 (VMRSX8)-transfected cells was used. L929 cells were cultured in 96-well plates at a density of 3 × 104 cells/well. After overnight incubation, cells were treated with actinomycin D (1 µg/ml) for 2 h at 37 °C in serum-free medium. After that, 100 µl/well of the VMRSX8-conditioned medium or VMR-0-conditioned medium were added. As indicated, recombinant human TNF (rhTNF) (Sigma) was added at a concentration of 10 ng/ml in a volume of 100 µl/well. To determine cell death, CytoTox 96 Assay kit (Promega) was used or cells were stained with trypan blue and the coded samples were counted under the microscope in a blind fashion, with a minimum of 100 cells scored for each group.
Neutralization of the cytotoxic effect of the Tag7 protein or rhTNF was performed using affinity-purified polyclonal rabbit anti-Tag7 and polyclonal anti-hTNF (Sigma) antibodies. Polyclonal antibodies were added to the VMRSX8-conditioned medium at a final concentration of 2 µg/ml, and the cytotoxic effect was determined as described above; rabbit IgG in the same concentration was used as a control.DNA Fragmentation Analysis-- DNA fragmentation analysis was performed as described (18), with modifications. In brief, 2 × 106 L929 cells were preincubated with actinomycin D (1 µg/ml) for 2 h at 37 °C in serum-free medium and subsequently incubated with the VMRSX8-conditioned medium or rhTNF for 5 h. Cells were harvested and lysed in 20 mM Tris-HCl, pH 8.0, 0.8% Triton X-100, 10 mM EDTA, pH 8.0. After centrifugation, DNA from the supernatant was precipitated at -20 °C by isopropanol in the presence of NaCl. DNA was resuspended in TE buffer (10 mM Tris-Cl, pH 7.4, 1 mM EDTA, pH 8.0) and treated with RNase A, and fragments were resolved in 1.8% agarose gel in TBE buffer (90 mM Tris-borate, 90 mM boric acid, 2 mM EDTA).
NF-B Activation Assay--
Nuclear extracts were obtained as
described in Ref. 19, and EMSA was performed according to Refs. 16 and
20. NF-
B consensus oligonucleotide (Promega) was used for gel shift
assay.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Isolation and Structure of the Murine tag7 Gene-- A system of two related mouse transplanted tumors with opposite metastatic potentials was used to isolate mRNA molecules specifically expressed in one of them. A fragment of complementary DNA was isolated by the differential display technique from the highly metastatic mouse mammary adenocarcinoma VMR-L as overexpressed mRNA in comparison with the nonmetastatic tumor VMR-0. The fragment gave rise to the 0.7-kb mRNA transcript specific for highly metastatic VMR-L tumor. This gene was designated tag7.
A cDNA library was constructed with mRNA from VMR-L tumor in a
|
Chromosomal Mapping of tag7-- To determine chromosomal localization of tag7 in mouse genome, metaphase chromosomes were analyzed by fluorescence in situ hybridization. A total of 80 metaphase cells were analyzed; 62 exhibited specific labeling. This experiment resulted in the specific labeling of the centromeric region of chromosome 7 (data not shown). Measurements of 10 specifically hybridized chromosomes 7 demonstrated that signal is located at a position that is 9% of the distance from the centromere, an area that corresponds to band 7A3.
Transcription of tag7 Is Specific for Lymphoid and Some Other Cells-- Northern hybridization was used to estimate the correlation between tag7 mRNA expression and metastatic properties of tumors. However, no correlation was observed upon hybridization with total RNA of CSML-0 and CSML-100 tumors (Fig. 2). Moreover, the expression of the tag7 gene appeared to be specific in this pair for the tumor with a low metastatic capacity, CSML-0. There was also no correlation between the metastatic potential and tag7 mRNA expression in other tested murine tumor cell lines (data not shown). The tag7 mRNA level dramatically altered after the establishment of the tumors as a cell culture (Fig. 2). In an established cell line from VMR-L tumors, the level of tag7 transcription dropped down, whereas in the CSML-0 cell line, obtained from corresponding tumors, it appeared to be up-regulated. Thus, tag7 in transplanted tumor is regulated by the host factors.
|
|
|
Tag7 Is a Secreted Protein and Secretion Can Be Activated in Lymphoid Cells-- To study Tag7 expression at the protein level, rabbit polyclonal antibodies raised against the E. coli Tag7 recombinant protein were used for Western blotting analysis of VMR-L and CSML-0 cells (Fig. 5A). The cells were separated from the cultivation medium and lysed. Proteins from both cellular lysates and cultivation medium were immunoprecipitated with anti-Tag7 antibodies, separated in polyacrylamide gel, and transferred to membrane. Most of the Tag7 protein was detected in conditioned medium of VMR-L cells (Fig. 5A). A similar pattern of gene expression was observed for another Tag7-expressing cell line, CSML-0 (data not shown). The level of tag7 transcription in CSML-0 cell line was higher than in VMR-L cells (Fig. 2); however, the level of protein synthesis remained low, and we were unable to detect Tag7 protein without immunoprecipitation with antibodies.
|
Secreted Tag7 Induces Cell Death in an Apoptotic Manner-- Recombinant E. coli Tag7 protein was isolated as a denatured protein from inclusion bodies. All of our attempts to refold the protein after purification on Ni-NTA column failed. During dialysis, the purified from the E. coli system material irreversibly precipitated. To perform functional studies with Tag7 protein, we constructed cell line constitutively producing Tag7.
The VMR-0 cell line, which does not express tag7 (Fig. 6A), was stably transfected with the constructions expressing the tag7 gene. For transfections, both pBK-CMV and pM5Gneo eucaryotic expression vectors were used; however, the pM5Gneo vector allowed us to obtain significantly higher level of Tag7 expression. We analyzed 15 G418-resistant clones on the level of Tag7 expression. In most of them, the level of the exogenous tag7 transcription was relatively high, but Tag7 protein synthesis remained hardly detectable. The clone with the highest level of Tag7 secretion (VMRSX8) (less than 10 ng/ml) was selected for further studies of soluble Tag7 protein. For this, L929 cells were treated with either conditioned supernatant from VMRSX8 cells or from the control mock-transfected VMR-0 cells for different time intervals. It was found that conditioned medium from VMRSX8 cells caused death in target L929 cells. Maximum cytotoxicity was observed at 5 h and did not increase significantly after 24 h incubation (Fig. 6B). The results obtained demonstrated that both TNF and Tag7 killed L929 cells in the presence of actinomycin D. Addition of anti-Tag7 polyclonal antibodies specifically blocked cell death caused by VMRSX8 supernatant and did not affect TNF-induced apoptosis. At the same time, anti-TNF antibodies did not block Tag7-induced cell death. The supernatant from VMR-0 cells did not possess any cytotoxic activity. Human breast adenocarcinoma cell line MCF7 was also susceptible to Tag7 killing (data not shown).
|
NF-B Accumulation Is Not Activated in Target Cells by
Tag7--
TNF has been shown to induce apoptosis and NF-
B
activation, two of the most important activities signaled by TNFR-1
(22). We investigated whether Tag7 does also activate NF-
B. VMR-0
cells stably transfected with tag7-expressing construct
(VMRSX8) did not show changed viability and proliferation. To
investigate the NF-
B activation in sensitive to Tag7 cells, L929
cells were treated with either conditioned supernatant from cells
transfected with tag7 (VMRSX8) or recombinant human TNF in
concentration 10 ng/ml. Nuclear extracts were prepared 2 h later,
and reacted with end-labeled NF-
B specific probe and subjected to
EMSA (Fig. 7). Tag7 did not induce
detectable NF-
B activation in L929 cells, although cytotoxicity of
Tag7 was significantly higher than that of TNF during short-term of
exposure of the cells to these cytotoxic agents.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
During the last decade, a number of TNF-related cytokines were
identified and cloned. Some of them are produced by tumor cells (11,
23). Using the "differential display" technique, we have isolated a
novel mouse gene with a remote homology to the TNF family of ligands.
It came out first from the genomic organization of the tag7
gene. It is similar to the mouse LT- three-exon structure and the
noncanonical TATA box with multiple transcription initiation sites. The
promoter regions of TNF, lymphotoxins, and tag7 genes show
similarity in regulatory elements, although their combination is unique
for each gene.
The tissue specificity of tag7 expression also resembles
that of mouse LT- expression with quite a few exceptions. In
situ hybridization analysis for tag7 on sections of
selected organs also demonstrated the pattern of the signal
distribution close to LT-
mRNA. The total level of
tag7 mRNA in brain was very low; however, specific cell
types gave a strong hybridization signal upon in situ
hybridization. Specific cortical areas of the brain (the hippocampus
and Purkinje cells of the cerebellum) (Fig. 3, B and
C) showed a high level of tag7 mRNA content.
The same pattern of gene transcription was observed for the mouse
LT-
(21) gene. Only minor differences in the patterns of
tag7 and LT-
mRNA distribution were observed.
Lymphoid and hematopoietic organs contained Tag7-expressing cells,
although in the thymus, the level of tag7 transcription was
very low. On the other hand, the level of tag7 transcription in spleen was very high, and on sections, tag7 mRNA was
detected almost everywhere (data not shown), whereas LT-
mRNA
was predominantly expressed in the white pulp. This implies that two
genes may still be differentially regulated and activated through
different signaling pathways. A significant level of tag7
transcription in lungs could be attributed to the large amount of
alveolar macrophages.
The presence in the regulatory region of the tag7 gene of
NF-B binding site supposed very fast response on well-known stimuli, e.g. LPS or phorbol 12-myristate 13-acetate, which could
result in increased transcription of the gene. We detected
down-regulation of tag7 transcription in lymphocytes at the
early stages of activation. A similar type of down-regulation of TNF
mRNA expression in macrophages is mediated through the regulation
of NF-
B activation (24, 25). The reduction in tag7
transcription indicates that additional nuclear factors may be missing
or that silencers may be activated in such a way that transcription of
the tag7 gene is prevented. Activation of the
tag7 gene expression was relatively low in splenocytes and
tumor cell lines expressing the gene: VMR-L and CSML-0. Alteration in
the level of tag7 transcription after establishment
transplanted tumors as a cell lines points to the participation of host
factors in tag7 transcription. It was further supported by
the observation that in B and T cell lines, we were unable to detect
tag7 mRNA, although its transcription was abundant in
freshly isolated splenocytes. However, we can not rule out the
possibility that splenocytes became activated due to isolation
procedure.
A constitutive level of tag7 expression in the lymphoid and hematopoietic tissues points to a role for this gene in immune system. Furthermore, it is evident that the main step in regulation cascade occurred at the posttranscriptional level. Even insignificant changes in the mRNA production result in a change of overall amount of protein synthesized and its secretion, although constitutive level of Tag7 protein in isolated lymphoid cells is rather high.
We did not find any significant homology for Tag7 with any known
proteins. However, similarity in genomic organization and expression
pattern with lymphotoxin- motivated us for more detailed amino acid
sequence analysis. Low homology allowed multiple alignments, but this
analysis revealed the existence of five regions of low homology in the
extracellular domains of the Tag7 polypeptide and TNF family members
(Fig. 8). In the first two regions, the level of identity with other TNF family ligands is relatively high,
especially in residues buried in the
-sheet interior (26). The rest
of the domains show less homology, but the buried residues are still
conservative. Moreover, gel filtration data support the similarity in
quaternary structure of Tag7 and TNF family ligands. Like lymphotoxins
and TNF itself, native secreted Tag7 was detected as a multimer, and
the molecular weight of the complex allows us to speculate that it
forms trimers. However, whether Tag7 forms homo- or heterotrimers
is unknown. Tag7 is rich in cysteine residues and, like LT-
,
contains 4 methionine residues (27).
|
The tag7 gene was mapped on mouse chromosome 7. Previously, it was observed that many of TNF-related genes are clustered in the genome. TNF/lymphotoxins genes are linked on mouse chromosome 17 and human chromosome 6 (28-30). The tag7 gene does not map on the same chromosome with other known TNF ligand family members. Chromosome location offers a possible in vivo role of the tag7 gene. The cytogenetic band 7A3 has been genetically linked with lupus-like nephritis in the MRL and New Zealand hybrid models of systemic lupus erythrematosus (31, 32). Although systemic lupus erythrematosus is unlikely to involve mutations with severe functional alterations, gene knockout experiments may provide insight into pathogenic process.
Tag7 released in conditioned medium possesses cytotoxicity and triggers
intranucleosomal DNA fragmentation in target cells in the same way as
many known members of the TNF family. Fragmentation of DNA is one of
the characteristics of apoptosis. We can not exclude possibility that
Tag7 acts via binding with known "death domain" receptors, but it
is unlikely that TNF receptor is involved in the apoptotic cell death
caused by Tag7. Cell lines that naturally produce Tag7 protein, such as
CSML-0 or VMR-0 (which was engineered to produce it) (33), are easily
susceptible to killing by TNF. Another piece of evidence that points to
the existence of a specific Tag7 receptor is the existence of different
pathways of signal transduction. In addition to inducing apoptosis, TNF
receptor 1, CD95 (Apo1), DR3, DR4, and DR5 can activate the
transcription factor NF-B (34-36), which controls expression of
multiple immunomodulatory genes (37). We did not detect up-regulation
of nuclear NF-
B in target L929 cells in the presence of secreted
Tag7 protein. However, we can not rule out the possibility that in
another system, Tag7 would induce NF-
B activation, as observed for
TRAIL (TNF-related apoptosis-inducing ligand) receptors (38).
A tumor can produce cytokine; this may have important consequences, which may be direct (promoting or inhibiting tumor growth) or indirect (changing such growth through interactions on the microenvironment). The effect of a single cytokine, however, cannot be readily predicted, because its presence induces other cytokine(s), which can significantly affect the primary action. Recent studies with the tumor cells transformed with tag7 demonstrated the important role of the gene in tumor growth.2
![]() |
ACKNOWLEDGEMENTS |
---|
We thank O. Borodulina and A. Ruzov for technical assistance and I. Korobko for help in manuscript preparation.
![]() |
FOOTNOTES |
---|
* This work was supported by International Association for the Promotion of Cooperation with Scientists from the New Independent States of the Former Soviet Union (INTAS) Grant N1010-CT93-0029, Pharmaceutical European Community Organization Grant ERB3530PL941128, the Russian Foundation for Basic Research, and the Moscow Anticancer Program.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) X86374 (cDNA) and Y12088 (genomic DNA).
§ These authors contributed equally to this work.
¶ To whom correspondence should be addressed. Tel.: 7-095-1359970; Fax: 7-095-1354105; E-mail: slk{at}mx.ibg.rssi.ru.
1 The abbreviations used are: IL, interleukin; TNF, tumor necrosis factor; rhTNF, recombinant human TNF; LT, lymphotoxin; LPS, lipopolysaccharide; kb, kilobase pair; bp, base pair.
2 S. L. Kiselev, O. S. Kustikova, E. V. Korobko, and G. P. Georgiev, manuscript in preparation.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|